The Anal Cancer Drugs Market is experiencing notable growth due to rising disease incidence, technological advancements in diagnostics, and evolving treatment paradigms. While anal cancer remains a relatively uncommon malignancy, its link to human papillomavirus (HPV) has intensified research efforts aimed at improving therapeutic outcomes. The Ana